Clinical Trials Browser

Neoplasm Metastasis × lorlatinib × Thoracic × Clear all

NCT06007937 2026-02-05

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

Phase 1/2 Recruiting

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Recurrence

NCT05167500 2023-03-30

LORLAPULM

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Neoplasm Metastasis